Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the general population.The focus extracorporeal shock wave (fEWST) is a non invasive treatment for various diseases. FESWT is new and potential treatment for peripheral nerve entrapment/ peripheral neuropathy . But there is still little known about the effects and long term effects of fESWT in the treatment of CTS.
The aim of this study is to determine the effectiveness of fESWT in patients with carpal tunnel syndrome compared to participants receiving only night splint. Therefore 40 patients with mild to moderate CTS (verified by nerve conduction velocity) will be randomized to receive either fESWT (1-session a week for 3 weeks) or sham fESWT(1-session a week for 3 weeks). All subjects will be asked to wear night splints.
Evaluation will be performed at baseline (VAS, hand grip, electrodiagnostic parameters, questionnaires), 3 weeks (VAS, hand grip, questionnaires), 12 and 24 weeks (VAS, hand grip, electrodiagnostic parameters, questionnaires) after treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active Comparator | Active Comparator | fESWT |
|
| Sham Comparator | Sham Comparator | Sham fESWT |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| focused extracorporeal shock wave therapy | Other | 40 Patients with mild to moderate CTS will be randomized to receive either fESWT (1-session a week for 3 weeks) or sham fESWT(1-session a week for 3 weeks). All subjects will be asked to wear night splints. |
| Measure | Description | Time Frame |
|---|---|---|
| VAS | Visual Analog Scale: Change from baseline of pain 3th,12th and 24th weeks after treatment. | baseline, 3th,12th and 24th weeks after treatment |
| Measure | Description | Time Frame |
|---|---|---|
| hand grip strength | hand grip strength: | baseline, 3th,12th and 24th weeks after treatment |
| distal motor latency of the median nerve | electrophysiological parameter, using nerve conduction velocity to measure distal motor latency and antidromic sensory nerve conduction velocity of the median nerve. Change from baseline in conduction velocity of median nerve on 12th and 24th weeks after treatment. |
Not provided
Inclusion Criteria:
- mild to moderate CTS verified by nerve conduction velocity
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Christina Gesslbauer, Dr. | Contact | 0043 40040043330 | christina.gesslbauer@meduniwien.ac.at | |
| Christina Gesslbauer | Contact |
| Name | Affiliation | Role |
|---|---|---|
| Richard Crevenna, Ao.Univ.-Prof. Dr., MMSc, MBA | Medical University of Vienna, Department of Physical Medicine, Rehabilitation and Occupational Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical University of Vienna, Department of Physical Medicine, Rehabilitation and Occupational Medicine | Recruiting | Vienna | Austria |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002349 | Carpal Tunnel Syndrome |
| ID | Term |
|---|---|
| D020423 | Median Neuropathy |
| D020422 | Mononeuropathies |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000074059 | Extracorporeal Shockwave Therapy |
| ID | Term |
|---|---|
| D014464 | Ultrasonic Therapy |
| D003972 | Diathermy |
| D006979 | Hyperthermia, Induced |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| sham focused extracorporeal shock wave therapy | Other | 40 Patients with mild to moderate CTS will be randomized to receive either fESWT (1-session a week for 3 weeks) or sham fESWT(1-session a week for 3 weeks). All subjects will be asked to wear night splints. |
|
| night splint | Other | 40 Patients with mild to moderate CTS will be randomized to receive either fESWT (1-session a week for 3 weeks) or sham fESWT(1-session a week for 3 weeks). All subjects will be asked to wear night splints. |
|
| baseline,12th and 24th weeks after treatment |
| sensory conduction velocity of the median nerve | electrophysiological parameter, using nerve conduction velocity to measure distal motor latency and antidromic sensory nerve conduction velocity of the median nerve. Change from baseline in conduction velocity of median nerve on 12th and 24th weeks after treatment. | baseline, 12th and 24th weeks after treatment |
| SF-36 | 36-item Short Form Health Survey: Change from baseline in quality of life 3th,12th and 24th weeks after treatment. | baseline, 3th,12th and 24th weeks after treatment |
| Boston Scale | Boston Symptom Severity Score: Change from baseline in severity of symptoms and functional status 3th,12th and 24th weeks after treatment. | baseline, 3th,12th and 24th weeks after treatment |
| D009422 | Nervous System Diseases |
| D009408 | Nerve Compression Syndromes |
| D012090 | Cumulative Trauma Disorders |
| D013180 | Sprains and Strains |
| D014947 | Wounds and Injuries |
| D026741 |
| Physical Therapy Modalities |
| D012046 | Rehabilitation |